Scholars@Duke

Reply to L. Fornaro et al.

Publication ,  Journal Article
Fuchs, CS; Niedzwiecki, D
Published in: J Clin Oncol
April 10, 2018
Published version (DOI) Link to item

Duke Scholars

Donna Niedzwiecki
Author Donna Niedzwiecki Biostatistics & Bioinformatics, Division of Biostatistics
Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Clin Oncol

DOI

10.1200/JCO.2017.77.1030

EISSN

1527-7755

Publication Date

April 10, 2018

Volume

36

Issue

11

Start / End Page

1179 / 1180

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Leucovorin
  • Humans
  • Fluorouracil
  • Epirubicin
  • Cisplatin
  • Chemoradiotherapy, Adjuvant
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Fuchs, C. S., & Niedzwiecki, D. (2018). Reply to L. Fornaro et al. J Clin Oncol, 36(11), 1179–1180. https://doi.org/10.1200/JCO.2017.77.1030
Fuchs, Charles S., and Donna Niedzwiecki. “Reply to L. Fornaro et al.” J Clin Oncol 36, no. 11 (April 10, 2018): 1179–80. https://doi.org/10.1200/JCO.2017.77.1030.
Fuchs CS, Niedzwiecki D. Reply to L. Fornaro et al. J Clin Oncol. 2018 Apr 10;36(11):1179–80.
Fuchs, Charles S., and Donna Niedzwiecki. “Reply to L. Fornaro et al.” J Clin Oncol, vol. 36, no. 11, Apr. 2018, pp. 1179–80. Pubmed, doi:10.1200/JCO.2017.77.1030.
Fuchs CS, Niedzwiecki D. Reply to L. Fornaro et al. J Clin Oncol. 2018 Apr 10;36(11):1179–1180.

Published In

J Clin Oncol

DOI

10.1200/JCO.2017.77.1030

EISSN

1527-7755

Publication Date

April 10, 2018

Volume

36

Issue

11

Start / End Page

1179 / 1180

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Leucovorin
  • Humans
  • Fluorouracil
  • Epirubicin
  • Cisplatin
  • Chemoradiotherapy, Adjuvant
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences